Impact of Real-Time Continuous Glucose Monitoring on Medication Use and Glycemic Control in Type 2 Diabetes Across Therapy Regimensdiabetes; metabolic syndrome and obesityIF02026-02-050OAAI
Exploring Combined Use of Continuous Glucose Monitoring and Anti-Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin探索连续血糖监测与抗糖尿病药物联合使用对未使用胰岛素的2型糖尿病患者血糖控制的疗效。endocrinology and metabolismIF02025-08-250OAAI
Risk of hypoglycaemia among people with type 2 diabetes not treated with insulin: A retrospective analysis of Medicare Advantage beneficiariesDIABETES OBESITY & METABOLISMIF5.72024-09-301PRE
Reduction in Diabetes-Related Hospitalizations and Medical Costs After Dexcom G6 Continuous Glucose Monitor Initiation in People with Type 2 Diabetes Using Intensive Insulin TherapyADVANCES IN THERAPYIF42024-04-156OAAI
Continuous Glucose Monitoring and Reduced Diabetes-Related Hospitalizations in Patients with Type 2 Diabetes and CKDKIDNEY360IF32024-02-153OAAI
The Impact of Glycemic Variability on the Relationship between Hypoglycemia and HbAlcDIABETESIF7.52021-06-010PRE
Understanding Gaps Between Daily Living and Clinical Settings in Chronic Disease Management: Qualitative StudyJOURNAL OF MEDICAL INTERNET RESEARCHIF62021-02-258OA
Assessing and predicting drug-induced anticholinergic risks: an integrated computational approachTHERAPEUTIC ADVANCES IN DRUG SAFETYIF3.42017-08-2514OAAI